Texas Instruments Details Annual Meeting Proposals, Board Opposes Shareholder Written Consent
TXN sits 45% above its 52-week low of $139.95 on light trading volume (0.2× avg).
Summary
Texas Instruments filed additional proxy materials detailing the proposals for its April 16, 2026 annual meeting, including the election of directors and a shareholder proposal for written consent which the Board recommends against.
Key Events · Corporate Governance and Compliance · TXN
-
Annual Meeting Agenda Set
The filing details the proposals for the upcoming Annual Meeting scheduled for April 16, 2026.
-
Director Elections
Twelve nominees are presented for election to the Board of Directors, all of whom are recommended by the Board.
-
Executive Compensation Vote
Shareholders will cast an advisory vote on the company's executive compensation.
-
Contested Shareholder Proposal
A shareholder proposal to permit stockholders to act by written consent is included, with the Board recommending against its adoption.
Analysis · TXN · Manufacturing
This DEFA14A provides the specific agenda for Texas Instruments' upcoming annual meeting, supplementing the definitive proxy statement. Key items include the election of twelve directors, an advisory vote on executive compensation, and the ratification of the independent auditor. Notably, the filing details a shareholder proposal seeking to permit stockholders to act by written consent, which the Board explicitly recommends against. This contested proposal highlights a governance issue that could impact shareholder influence and corporate decision-making outside of scheduled meetings. Investors should review the full proxy materials to understand the implications of these proposals.
At the time of this filing, TXN was trading at $203.57 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $184.8B. The 52-week trading range was $139.95 to $231.32. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.